News
Modern drug discovery needs to be fast. Not long ago, pharmaceutical organizations prioritized cost efficiency above all else, with an ...
Cambridge, UK – March 29th, 2022 – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the ...
We were delighted to welcome Dr Ashraf Zarkan from the Department of Genetics, University of Cambridge to deliver a webinar ...
Globachem renews contract with Cresset Discovery Cambridge, UK - 08 February 2022 - Cresset Discovery, provider of contract consulting for early ...
Introduction The role of water in drug discovery should never be ignored. Its importance in ligand binding is well accepted ...
The power of Free Energy Perturbation (FEP) to effectively predict binding affinity and facilitate ligand design has been widely demonstrated ...
I want to take the opportunity to thank all of our customers, existing and new, for their support of Cresset ...
As a specialist CADD CRO, Cresset Discovery applies sophisticated computational approaches and extensive cross-industry expertise to support pharmaceutical and biotech ...
Cambridge, UK – 14 September 2021 – Cresset Discovery Services, provider of contract research services for early phase of drug ...
Drug discovery is an increasingly complex process with significant time and costs needed to develop a new drug from hypothesis ...
High-throughput virtual screening is a powerful computational technique for exploring new chemical space, discovering diverse chemotypes and generating new IP ...
Following on from his blog on 'The case for outsourcing computational chemistry in drug discovery', Dr Martin Slater, Director of ...